Francis Knuettel II - Nov 1, 2024 Form 3 Insider Report for Innovation1 Biotech Inc. (IVBT)

Role
Chairman and Interim CEO, Director
Signature
/s/ Francis Knuettel II
Stock symbol
IVBT
Transactions as of
Nov 1, 2024
Transactions value $
$0
Form type
3
Date filed
2/4/2025, 06:54 AM
Previous filing
Sep 16, 2024
Next filing
Apr 15, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVBT Series C Senior Convertible Preferred Stock Nov 1, 2024 Common Stock 1.02B By Camden Capital LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person holds 600,000 shares of Series C Senior Convertible Preferred Stock. Each share of Series C Senior Convertible Preferred Stock is convertible into shares of the Issuer's common stock at any time by dividing the Stated Value of $0.001 by the Conversion Price of $0.000000586216897634410.
F2 Represents shares of Series C Senior Convertible Preferred Stock held by Camden Capital LLC, an entity which the Reporting Person holds voting and investment control.
F3 Conversion Price is $0.000000586216897634410.